23andMe (ME) - 2024 Q4 - Annual Results

EXHIBIT 99.1 23andMe Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results SOUTH SAN FRANCISCO, Calif., May 23, 2024 -- 23andMe Holding Co. (Nasdaq: ME), a leading human genetics and biopharmaceutical company, reported its financial results for the fourth quarter and full year of fiscal year 2024 (FY24), which ended March 31, 2024. Key Results and Recent Developments "The Company had a productive fourth quarter and solid end to the year, continuing to add value for members of 23andMe+ and advan ...